EP3113782
Lyfjadreifingarkerfi og aðferðir til meðhöndlunar á krabbameini í þvagblöðru með gemsítabíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.3.2015EP published:
28.9.2022EP application number:
15711373.9
EP translation filed:
28.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
5.3.2035Expiry date:
5.3.2027Next due date:
31.3.2027
Title in English:
DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER CANCER WITH GEMCITABINELanguage of the patent:
English
Timeline
Today
6.3.2015EP application
28.9.2022EP Publication
28.11.2022Translation submitted
15.12.2022Registration published
5.3.2027Expires
Owner
Name:
TARIS Biomedical LLCAddress:
113 Hartwell Ave, Lexington, MA 02421, US
Inventor
Name:
GIESING, DennisAddress:
Lee's Summit, Missouri 64082, US
Name:
LEE, HeejinAddress:
Bedford, Massachusetts 01730, US
Name:
DANIEL, KarenAddress:
Newtonville, Massachusetts 02460-2021, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461949215 PDate:
6.3.2014Country:
US
Classification
Categories:
A61K 9/00, A61K 31/7068, A61P 13/10, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.2.2023
Expires: 5.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2024
Expires: 5.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.2.2025
Expires: 5.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.3.2026
Expires: 5.3.2027
Payer: Árnason Faktor ehf.